Lactoferrin-Enriched Whey for Iron-Deficiency Anemia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how a special drink mix can improve iron levels and reduce inflammation in active young women with iron-deficiency anemia. Participants will consume a drink enriched with lactoferrin (a protein found in milk), iron, and vitamin B12 twice daily for 16 weeks. The trial includes different groups testing variations with lactoferrin-enriched whey protein, rice protein, or maltodextrin. Women who exercise regularly and experience issues related to low iron might be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to research that could benefit others with similar health concerns.
Do I have to stop taking my current medications?
You may need to stop taking certain medications or supplements that affect the study outcomes, like NSAIDs, corticosteroids, or iron supplements, if they can't be temporarily discontinued for the study.
Will I have to stop taking my current medications?
If you are taking medications or supplements that affect the study's outcome measures, like NSAIDs, corticosteroids, or iron supplements, you may need to stop them temporarily for this study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that lactoferrin, when combined with iron and vitamin B12, is generally safe for people. Studies suggest that bovine lactoferrin (a protein from cow's milk) is safe to include in diets and is recognized as safe (GRAS) for consumption, meaning people can usually take it without worrying about serious side effects.
Other studies have found that treatments enriched with lactoferrin have very few side effects. This includes those mixed with proteins like whey or rice, as well as with maltodextrin (a carbohydrate used in foods). These combinations have been used to improve iron levels and appear safe based on current research.
Overall, evidence suggests that the treatments being studied, whether mixed with whey, rice, or maltodextrin, are well-tolerated and safe.12345Why are researchers excited about this trial's treatments?
Unlike the standard treatments for iron-deficiency anemia, which typically involve oral or intravenous iron supplements, these investigational treatments incorporate lactoferrin paired with iron and B12 in different protein bases. Researchers are particularly excited about the potential of lactoferrin, a natural protein known for enhancing iron absorption and having anti-inflammatory properties. The use of different protein bases like whey, rice, and maltodextrin could offer tailored options for patients with specific dietary preferences or restrictions. This combination might lead to improved iron absorption, reduced side effects, and an overall more efficient treatment for iron-deficiency anemia.
What evidence suggests that this trial's treatments could be effective for iron-deficiency anemia?
Research has shown that combining lactoferrin with iron and vitamin B12 can greatly improve iron levels. Studies have found that these nutrients together increase hemoglobin (the protein in red blood cells that carries oxygen) and raise red blood cell counts in people with low iron. This combination also reduces inflammation, which helps the body absorb iron better. In this trial, participants will receive different formulations of lactoferrin, iron, and B12. Specifically, using lactoferrin in a whey protein drink, one of the study arms, improved iron levels more effectively than using non-milk proteins like rice, which is another arm in this trial. This suggests that the combination could be especially helpful for improving iron metabolism in young, active women.13467
Are You a Good Fit for This Trial?
This trial is for active young women aged 18-30 with a BMI of 18-30 kg/m2 who are experiencing iron-deficiency anemia. Participants should exercise regularly, speak and understand English, and be able to give informed consent. It's not suitable for those outside these criteria.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume assigned supplements twice daily for 16 weeks
Mid-intervention Check-in
Participants complete a 7-day food log and other questionnaires
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Lactoferrin, Iron and B12 in Maltodextrin
- Lactoferrin, Iron and B12 in Rice Protein
- Lactoferrin, iron and B12 in Whey Protein
Lactoferrin, Iron and B12 in Maltodextrin is already approved in United States, European Union for the following indications:
- Iron deficiency anemia
- Inflammation reduction
- Iron deficiency anemia
- Inflammation reduction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Utah State University
Lead Sponsor
BUILD Dairy
Collaborator
Glanbia Nutritionals
Industry Sponsor